Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Jourdan

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Oncogene|March 1, 2005
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cellsKarène Mahtouk, Dirk Hose, Thierry Rème, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiationMichel Jourdan, Anouk Caraux, Gersende Caron, et al.
Frontiers in Immunology|December 26, 2022
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistanceSara Ovejero, Elena Viziteu, Laure Dutrieux, et al.
Blood|February 21, 2009
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptorAnne Catherine Sprynski, Dirk Hose, Laurent Caillot, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Oncogene|March 1, 2005
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cellsKarène Mahtouk, Dirk Hose, Thierry Rème, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiationMichel Jourdan, Anouk Caraux, Gersende Caron, et al.
Frontiers in Immunology|December 26, 2022
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistanceSara Ovejero, Elena Viziteu, Laure Dutrieux, et al.
Blood|February 21, 2009
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptorAnne Catherine Sprynski, Dirk Hose, Laurent Caillot, et al.
Pageof 4